Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David Chin
APOMAB® Antibody Drug Conjugates Targeting Dead Tumor Cells Are Effective in Vivo
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Antibody-Drug Conjugates With HER2-targeting Antibodies From Synthetic Antibody Libraries Are Highly Potent Against HER2-positive Human Gastric Tumor in Xenograft Models
mAbs
Allergy
Immunology
Antibody-Drug Conjugates in Bladder Cancer
Bladder Cancer
Oncology
Urology
The Antitumor Activity of TCR-Mimic Antibody-Drug Conjugates (TCRm-ADCs) Targeting the Intracellular Wilms Tumor 1 (WT1) Oncoprotein
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
The Promise of Antibody–Drug Conjugates
New England Journal of Medicine
Medicine
Antibody – Drug Conjugates (ADC) – Drug Discovery Today: Technologies
Drug Discovery Today: Technologies
Biotechnology
Drug Discovery
Molecular Medicine
Studies on Antibody-Anticancer Drug Conjugates
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
Drug Conjugates for Targeting Eph Receptors in Glioblastoma
Pharmaceuticals
Molecular Medicine
Pharmaceutical Science
Immunochemotherapy With Tumor Antibody-Neocarzinostatin (NCS) Conjugates
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
P2.06-08 ABT-806 Derived Antibody Drug Conjugates (ADCs) Inhibit Growth of Malignant Mesothelioma In-Vivo
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
